CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
The treatment outcomes of patients with chronic lymphocytic leukemia (CLL) have considerably improved with the introduction of targeted therapies based on Bruton kinase inhibitors (BTKIs), venetoclax, and anti-CD20 monoclonal antibodies. However, despite these consistent improvements, patients who...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
PAGEPress Publications
2024-04-01
|
| シリーズ: | Mediterranean Journal of Hematology and Infectious Diseases |
| 主題: | |
| オンライン･アクセス: | https://www.mjhid.org/mjhid/article/view/5696 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|